Dated changes to published GLP-1 self-pay prices, from manufacturer announcements and our own checks.https://glp.observer/enhttps://glp.observer/changes/#c-2026-10-19-wegovy/https://glp.observer/changes/#c-2026-10-19-wegovy/Observed: Novo’s $199 intro price now runs through December 31, 2026; Wegovy HD 7.2 mg is $399; Wegovy pill $149–$299 by dose.Mon, 19 Oct 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-10-19-saxenda/https://glp.observer/changes/#c-2026-10-19-saxenda/Observed: NovoCare notice that Saxenda will be discontinued, with last shipments to wholesalers in late January 2027 (not a safety or quality issue).Mon, 19 Oct 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-10-19-rybelsus/https://glp.observer/changes/#c-2026-10-19-rybelsus/Observed: Novo says Rybelsus is being replaced by the Ozempic pill; the Rybelsus savings-offer page now opens the Ozempic offer.Mon, 19 Oct 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-10-19-foundayo/https://glp.observer/changes/#c-2026-10-19-foundayo/Observed: Foundayo 2.5 mg temporarily $149 (regular $199) and 5.5 mg $199 (regular $299) through December 31, 2026.Mon, 19 Oct 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-10-19-zepbound/https://glp.observer/changes/#c-2026-10-19-zepbound/Observed: Zepbound late-refill (regular) prices are now $499 for 7.5 mg and $699 for 10–15 mg, versus $599–$1,049 in Lilly’s Dec 2025 release.Mon, 19 Oct 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-07-01-medicare/https://glp.observer/changes/#c-2026-07-01-medicare/Medicare GLP-1 Bridge starts: eligible Part D enrollees pay $50 a month for Wegovy, Foundayo and the Zepbound KwikPen, through December 31, 2027.Wed, 01 Jul 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-04-09-foundayo/https://glp.observer/changes/#c-2026-04-09-foundayo/Foundayo (orforglipron) pill launches; self-pay from $149 a month at the lowest dose, $25 with commercial coverage.Thu, 09 Apr 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-02-24-wegovy/https://glp.observer/changes/#c-2026-02-24-wegovy/Novo Nordisk announces it will cut the list price of Wegovy, Ozempic and Rybelsus to $675 a month from January 1, 2027; self-pay prices are not affected.Tue, 24 Feb 2026 12:00:00 GMThttps://glp.observer/changes/#c-2026-02-23-zepbound/https://glp.observer/changes/#c-2026-02-23-zepbound/Zepbound KwikPen (four doses, one month) launches on LillyDirect at the same self-pay prices as vials, from $299.Mon, 23 Feb 2026 12:00:00 GMThttps://glp.observer/changes/#c-2025-12-01-zepbound/https://glp.observer/changes/#c-2025-12-01-zepbound/Zepbound vials cut to $299 (2.5 mg), $399 (5 mg) and $449 (7.5–15 mg with on-time refills).Mon, 01 Dec 2025 12:00:00 GMThttps://glp.observer/changes/#c-2025-11-17-wegovy/https://glp.observer/changes/#c-2025-11-17-wegovy/Wegovy and Ozempic self-pay cut from $499 to $349 (Ozempic 2 mg stays $499); new-patient intro price of $199 for the first two fills of 0.25 and 0.5 mg.Mon, 17 Nov 2025 12:00:00 GMThttps://glp.observer/changes/#c-2025-03-24-wegovy/https://glp.observer/changes/#c-2025-03-24-wegovy/The $499 Wegovy offer extends to retail pharmacies via the savings offer, replacing a $650-a-month offer.Mon, 24 Mar 2025 12:00:00 GMThttps://glp.observer/changes/#c-2025-03-05-wegovy/https://glp.observer/changes/#c-2025-03-05-wegovy/NovoCare Pharmacy launches with all Wegovy pen doses at $499 a month for cash-paying patients.Wed, 05 Mar 2025 12:00:00 GMThttps://glp.observer/changes/#c-2025-02-25-zepbound/https://glp.observer/changes/#c-2025-02-25-zepbound/Zepbound 2.5 mg vial cut to $349 and 5 mg to $499; new 7.5 mg and 10 mg vials at $499 with on-time refills (regular $599 / $699).Tue, 25 Feb 2025 12:00:00 GMThttps://glp.observer/changes/#c-2024-08-27-zepbound/https://glp.observer/changes/#c-2024-08-27-zepbound/Lilly launches Zepbound single-dose vials on LillyDirect: 2.5 mg $399, 5 mg $549 per four-week supply.Tue, 27 Aug 2024 12:00:00 GMT